CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of ...

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) — Black Diamond Group Limited (TSX: BDI, OTCQX:BDIMF) (“Black Diamond” or the “Company”) announces that it has obtained approval of the ...

Diamond’s hybrid powertrain combines batteries and ... Login with your existing email and password Not a member? Learn how to access the market intelligence and data you need to stay abreast ...

Shares of Black Diamond Therapeutics rose sharply in premarket trading Wednesday after the clinical-stage oncology company said it inked a licensing agreement potentially worth hundreds of ...

Under the agreement, Servier will develop and commercialize BDTX-4933, a small molecule designed by Black Diamond Therapeutics for RAF/RAS-mutant solid tumors. Under the terms of the deal ...

Black Diamond Group has a fifty-two week low of C$7.40 and a fifty-two week high of C$10.27. In related news, Senior Officer Tobias Gerald Labrie sold 3,540 shares of the stock in a transaction on ...

The Black Diamond is a new private dining experience at The Lindis, a luxury lodge in New Zealand’s Ahuriri Valley. This summer, Viva Premium is revisiting the best and biggest stories of the year.

Based on a brand-new 2023 Mercedes-Benz Sprinter with a 144" wheelbase and a high roof, this beautiful van conversion is called Black Diamond. It is a two-berth camper aimed at folks who demand ...

Located on a five-acre former brownfield site at 2923 Park Ave. in the Westmoreland neighborhood of Huntington, the Black Diamond project is an initiative to redevelop an area once central to ...

Vice President Kamala Harris is ramping up her outreach to Black men, pledging to provide outlets for economic security, as polls show Donald Trump is gaining support among Black voters.

CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of ...